110 related articles for article (PubMed ID: 2165046)
1. A monoclonal antibody that neutralizes Epstein-Barr virus DNA polymerase activity.
Tsai CH; Williams MV; Glaser R
Intervirology; 1990; 31(2-4):215-22. PubMed ID: 2165046
[TBL] [Abstract][Full Text] [Related]
2. A monoclonal antibody that neutralizes Epstein-Barr virus, human cytomegalovirus, human herpesvirus 6, and bacteriophage T4 DNA polymerases.
Tsai CH; Williams MV; Glaser R
Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7963-7. PubMed ID: 1700422
[TBL] [Abstract][Full Text] [Related]
3. A comparison of Epstein-Barr virus specific proteins expressed by three Epstein-Barr virus isolates using specific monoclonal antibodies.
Tsai CH; Glaser R
Intervirology; 1991; 32(6):376-82. PubMed ID: 1657827
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel EBV-induced membrane glycoprotein of 43 kDa with H667 MAb.
Sanchez-Pinel A; Bernad J; Rives H; Lapchine L; Icart J; Didier J
Virology; 1991 Jan; 180(1):31-40. PubMed ID: 1845828
[TBL] [Abstract][Full Text] [Related]
5. Specific immune serum to the Epstein-Barr virus DNA polymerase.
Petit RG; Leung K; Shaw JE
J Virol; 1987 Oct; 61(10):3331-4. PubMed ID: 3041054
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.
Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE
J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody specific for capsid antigen of Epstein-Barr virus.
Takada K; Fujiwara S; Yano S; Osato T
Med Microbiol Immunol; 1983; 171(4):225-31. PubMed ID: 6304479
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of Epstein-Barr virus-specific DNA polymerase in chemically induced Raji cells and its antibody in serum from patients with nasopharyngeal carcinoma.
Tan RS; Li JS; Grill SP; Nutter LM; Cheng YC
Cancer Res; 1986 Oct; 46(10):5024-8. PubMed ID: 3019519
[TBL] [Abstract][Full Text] [Related]
9. Production of human monoclonal antibodies against Epstein-Barr virus-specific antigens by the virus-immortalized lymphoblastoid cell lines.
Koizumi S; Fujiwara S; Kikuta H; Okano M; Imai S; Mizuno F; Osato T
Virology; 1986 Apr; 150(1):161-9. PubMed ID: 3006333
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus (EBV) replication and expressions of EA-D (BMRF1 gene product), virus-specific deoxyribonuclease, and DNA polymerase in EBV-activated Akata cells.
Daibata M; Sairenji T
Virology; 1993 Oct; 196(2):900-4. PubMed ID: 8396819
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome.
Jones JF; Williams M; Schooley RT; Robinson C; Glaser R
Arch Intern Med; 1988 Sep; 148(9):1957-60. PubMed ID: 2843138
[TBL] [Abstract][Full Text] [Related]
12. Construction and characterization of monoclonal antibodies specific for the R transactivator 185 of Epstein-Barr virus.
Zhu YH; Wei YS; Li H; Liang WB; Du B; Zhang GQ; Zhang L
J Virol Methods; 2007 Sep; 144(1-2):12-6. PubMed ID: 17532480
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a 75-kDa Epstein-Barr virus capsid protein using a new monoclonal antibody H250.
Sanchez-Pinel A; Bernad J; Rives H; Icart J; Didier J
Res Virol; 1989; 140(6):531-43. PubMed ID: 2559442
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220.
Sairenji T; Bertoni G; Medveczky MM; Medveczky PG; Nguyen QV; Humphreys RE
J Virol; 1988 Aug; 62(8):2614-21. PubMed ID: 2839689
[TBL] [Abstract][Full Text] [Related]
15. [Studies on Epstein-Barr virus strain differences with monoclonal antibodies].
Yang ZH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Feb; 11(1):41-5. PubMed ID: 2548745
[TBL] [Abstract][Full Text] [Related]
16. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody.
Maunders MJ; Petti L; Rowe M
J Gen Virol; 1994 Apr; 75 ( Pt 4)():769-78. PubMed ID: 7512118
[TBL] [Abstract][Full Text] [Related]
17. Association of Epstein-Barr virus early antigen diffuse component and virus-specified DNA polymerase activity.
Li JS; Zhou BS; Dutschman GE; Grill SP; Tan RS; Cheng YC
J Virol; 1987 Sep; 61(9):2947-9. PubMed ID: 3039183
[TBL] [Abstract][Full Text] [Related]
18. Characterization of two monoclonal antibodies to Epstein-Barr virus diffuse early antigen which react to two different epitopes and have different biological function.
Tsai CH; Williams MV; Glaser R
J Virol Methods; 1991 Jun; 33(1-2):47-52. PubMed ID: 1719014
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus strain- and group-specific antigenic determinants detected by monoclonal antibodies.
Mueller-Lantzsch N; Georg-Fries B; Herbst H; zur Hausen H; Braun DG
Int J Cancer; 1981 Sep; 28(3):321-7. PubMed ID: 6172392
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells.
Rowe M; Evans HS; Young LS; Hennessy K; Kieff E; Rickinson AB
J Gen Virol; 1987 Jun; 68 ( Pt 6)():1575-86. PubMed ID: 2438376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
